THIADIAZOLINE DERIVATIVE

see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic g...

Full description

Saved in:
Bibliographic Details
Main Authors KATO, KAZUHIKO, MURAKATA, CHIKARA, YAMASHITA, YOSHINORI, INO, YOJI, NAKAI, RYUICHIRO, TAKAHASHI, TAKESHI, NAKANO, TOMOHISA, OHTA, YOSHIHISA
Format Patent
LanguageEnglish
French
Published 21.06.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents -C(=W)R6 or the like; R3 represents a hydrogen atom, -C(=WA)R 6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
Bibliography:Application Number: CA20022469801